DEVELOPMENT OF A HOMOGENEOUS LIGAND INTERACTION ASSAY

Information

  • Research Project
  • 2794838
  • ApplicationId
    2794838
  • Core Project Number
    R43GM057116
  • Full Project Number
    1R43GM057116-01A1
  • Serial Number
    57116
  • FOA Number
  • Sub Project Id
  • Project Start Date
    3/1/1999 - 25 years ago
  • Project End Date
    8/31/1999 - 24 years ago
  • Program Officer Name
  • Budget Start Date
    3/1/1999 - 25 years ago
  • Budget End Date
    8/31/1999 - 24 years ago
  • Fiscal Year
    1999
  • Support Year
    1
  • Suffix
    A1
  • Award Notice Date
    3/1/1999 - 25 years ago
Organizations

DEVELOPMENT OF A HOMOGENEOUS LIGAND INTERACTION ASSAY

The long-term goal of this project is to develop a non- radioactive homogeneous assay suitable for studying macromolecular interactions. The assay would be a widely applicable technique useful in research, diagnostic, and drug discovery. Recent proliferation of combinatorial chemistry techniques has mad libraries increasingly larger, inexpensive, and tailored to specific application. The ability to rapidly identify antagonistic compounds has importance in fields as diverse as basic research, diagnostics, and drug screening. Currently no homogeneous, non-radioactive technique exists which is suited to a range of macromolecular types and interactions. The proposed colloidal silver aggregation assay format meets this need by providing a fast optical readout regarding interaction between two ligands. Preliminary studies have used model systems to demonstrate the feasibility of this technology. These studies reveal the need for an organic monolayer on the metal to provide macromolecular coupling sites and protect ligand from direct metal contact. Our specific aims for Phase I are to construct and characterize colloid monolayers, assess aggregation using covalently coupled ligands and explore various functional parameters of such an assay. Completion of this research will result in a novel high-through put assay for ligand interactions capable of identifying compounds which affect binding. PROPOSED COMMERCIAL APPLICATIONS: This research may result in the development of a novel, homogeneous, optical assay for use in identifying inhibitors of ligand interactions.

IC Name
NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES
  • Activity
    R43
  • Administering IC
    GM
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    821
  • Ed Inst. Type
  • Funding ICs
  • Funding Mechanism
  • Study Section
    ZRG3
  • Study Section Name
  • Organization Name
    UNION BIOMETRICA, INC.
  • Organization Department
  • Organization DUNS
  • Organization City
    HOLLISTON
  • Organization State
    MA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    017461371
  • Organization District
    UNITED STATES